Contents
The COVID-19 vaccine in the form of a patch that will protect you for decades? The British company Emergex will soon start researching such a preparation. This was reported by the British newspaper «The Guardian». How is such a vaccine supposed to work? When can it be available?
- The British company Emergex has received permission to test an innovative vaccine against COVID-19.
- The preparation is to be in the form of a plaster and will provide protection for decades
- The vaccine trials are scheduled to start on January 3, 2022, with preliminary results expected in June, and the preparation could be available from 2025.
- More current information can be found on the Onet homepage.
Innovative vaccine against COVID-19. Research begins
British pharmaceutical company Emergex has received approval from the Swiss regulator to test the new vaccine on 26 people in Lausanne. The research is to start on January 3, 2022. Initial results are expected in June next year.
The innovative preparation may be available from 2025, according to the standard, and not accelerated, schedule of work on the preparation. The crisis situation is over, which increased the pace of work within the regulatory process in introducing currently available vaccines to the market – Emergex Commercial Director Robert Cohen pointed out.
– For the first time, a regulatory body has approved a vaccine for clinical trials that aims to generate a targeted T-cell response in the absence of an antibody response. T cells look for infected cells in the body and kill them, Cohen said. – A virus is like an asteroid being launched into a planet. The virus code, which is a kind of virus signature, is quickly displayed over the entire surface of the attacked object. The codes are read by T cells as foreign. Therefore, the captured cell is rendered harmless before new, live viruses can multiply in it, he explained.
The COVID-19 vaccine in the form of a patch. How it’s working?
Danny Altmann, professor of immunology at Imperial College London, said he doubts that the T-cell vaccine “is capable of doing the job by itself”, but in his view it could play a complementary role in a vaccine blending approach.
A patch the size of a human thumb, bristling with microneedles, is designed to release its composition in a few seconds. It can be stored at room temperature for up to several months.
Do you want to test your COVID-19 immunity after vaccination? Have you been infected and want to check your antibody levels? See the COVID-19 immunity test package, which you will perform at Diagnostics network points.
Emergex is also testing T-cell vaccines against dengue, which, according to the World Health Organization, is at risk of half of the world’s population. So far, neither medicinal preparations nor preparations protecting against infection with the virus of this disease have been developed.
The way T lymphocytes work is also to be used in the development of vaccines against Ebola, the Zika virus and seasonal influenza.
You may be interested in:
- Dr. Sutkowski: Before his death, many people regret that they did not get vaccinated earlier
- Possible new COVID-19 vaccine. It is different from the rest. How it works?
- Will a fourth dose of COVID-19 vaccine be needed? What is known about this topic?
The content of the medTvoiLokony website is intended to improve, not replace, the contact between the Website User and their doctor. The website is intended for informational and educational purposes only. Before following the specialist knowledge, in particular medical advice, contained on our Website, you must consult a doctor. The Administrator does not bear any consequences resulting from the use of information contained on the Website. Do you need a medical consultation or an e-prescription? Go to halodoctor.pl, where you will get online help – quickly, safely and without leaving your home.